// App-Quantinova.ai

: Predicting SGRQ score based on CAT score: post-hoc analysis of the IMPACT trial

Researchers

Presenter

  • Paul Jones

Principal Investigators

  • Soham Shukla

  • Lee Tombs

  • Afisi Ismaila

  • Alan Martin

  • Dawn Midwinter

  • Isabelle Boucot

  • Nancy Risebrough

  • Claus Vogelmeier

Medical Centers

  • Philipps Univ Marburg, Marburg, Germany

  • GlaxoSmithKline, Uxbridge, United Kingdom

  • GlaxoSmithKline plc, Collegeville, United States of America

  • GlaxoSmithKline Plc, Brentford, United Kingdom

  • ICON plc., Toronto, ON, Canada

  • Precise Approach Ltd, London, United Kingdom

Locations

  • United States

  • Germany

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Catalase

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT02164513

Sponsors

  • N/A

Result

  • N/A